Free Trial
NYSE:BLCO

Bausch + Lomb (BLCO) Stock Price, News & Analysis

Bausch + Lomb logo
$13.83 +0.07 (+0.51%)
Closing price 07/3/2025 03:56 PM Eastern
Extended Trading
$13.67 -0.16 (-1.16%)
As of 07/3/2025 04:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Bausch + Lomb Stock (NYSE:BLCO)

Key Stats

Today's Range
$13.68
$13.97
50-Day Range
$10.90
$13.83
52-Week Range
$10.45
$21.69
Volume
618,722 shs
Average Volume
713,491 shs
Market Capitalization
$4.89 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$15.54
Consensus Rating
Hold

Company Overview

Bausch + Lomb Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
68th Percentile Overall Score

BLCO MarketRank™: 

Bausch + Lomb scored higher than 68% of companies evaluated by MarketBeat, and ranked 967th out of 2,814 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Bausch + Lomb has received a consensus rating of Hold. The company's average rating score is 2.23, and is based on 4 buy ratings, 8 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Bausch + Lomb has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Bausch + Lomb's stock forecast and price target.
  • Earnings Growth

    Earnings for Bausch + Lomb are expected to grow by 29.73% in the coming year, from $0.74 to $0.96 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Bausch + Lomb is -13.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Bausch + Lomb is -13.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    Bausch + Lomb has a PEG Ratio of 1.55. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Bausch + Lomb has a P/B Ratio of 0.74. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Bausch + Lomb's valuation and earnings.
  • Percentage of Shares Shorted

    7.18% of the float of Bausch + Lomb has been sold short.
  • Short Interest Ratio / Days to Cover

    Bausch + Lomb has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Bausch + Lomb has recently increased by 3.15%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Bausch + Lomb does not currently pay a dividend.

  • Dividend Growth

    Bausch + Lomb does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    7.18% of the float of Bausch + Lomb has been sold short.
  • Short Interest Ratio / Days to Cover

    Bausch + Lomb has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Bausch + Lomb has recently increased by 3.15%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Bausch + Lomb has a news sentiment score of 0.35. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.54 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 11 news articles for Bausch + Lomb this week, compared to 6 articles on an average week.
  • Search Interest

    4 people have searched for BLCO on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added Bausch + Lomb to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Bausch + Lomb insiders have bought more of their company's stock than they have sold. Specifically, they have bought $248,160.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 0.76% of the stock of Bausch + Lomb is held by insiders.

  • Percentage Held by Institutions

    Only 11.07% of the stock of Bausch + Lomb is held by institutions.

  • Read more about Bausch + Lomb's insider trading history.
Receive BLCO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bausch + Lomb and its competitors with MarketBeat's FREE daily newsletter.

BLCO Stock News Headlines

Post-Halving = Profit Season (Here’s How to Win It)
It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how to trade it, this phase brings the most potential. We’re now in that window. A free workshop outlines how a proven system is targeting daily wins, passive income, and explosive upside through curated altcoin picks. Whether you're new to crypto or looking to catch the next move with confidence, this is your roadmap. And just for showing up, you’ll receive $10 in real Bitcoin. Don’t miss it.
Bausch + Lomb to Announce Q2 2025 Results and Host Investor Day
BLCO Stock Price Quote - Morningstar
Insider Stock Buying Reaches US$1.54m On Bausch + Lomb
See More Headlines

BLCO Stock Analysis - Frequently Asked Questions

Bausch + Lomb's stock was trading at $18.06 at the start of the year. Since then, BLCO shares have decreased by 23.4% and is now trading at $13.83.

Bausch + Lomb Corporation (NYSE:BLCO) posted its earnings results on Wednesday, April, 30th. The company reported ($0.07) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.03 by $0.10. The business's revenue for the quarter was up 3.5% compared to the same quarter last year.
Read the conference call transcript
.

Bausch + Lomb (BLCO) raised $788 million in an IPO on Friday, May 6th 2022. The company issued 35,000,000 shares at $21.00-$24.00 per share.

Shares of BLCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Bausch + Lomb investors own include PayPal (PYPL), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), Walt Disney (DIS), Intel (INTC) and Devon Energy (DVN).

Company Calendar

Last Earnings
4/30/2025
Today
7/04/2025
Next Earnings (Estimated)
7/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Medical Services
Sub-Industry
Medical Equipment
Current Symbol
NYSE:BLCO
Fax
N/A
Employees
13,500
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$15.54
High Stock Price Target
$19.00
Low Stock Price Target
$12.00
Potential Upside/Downside
+12.4%
Consensus Rating
Hold
Rating Score (0-4)
2.23
Research Coverage
13 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
18.69
P/E Growth
1.55
Net Income
-$317 million
Pretax Margin
-6.71%

Debt

Sales & Book Value

Annual Sales
$4.83 billion
Cash Flow
$1.88 per share
Price / Cash Flow
7.35
Book Value
$18.57 per share
Price / Book
0.74

Miscellaneous

Free Float
351,033,000
Market Cap
$4.89 billion
Optionable
Optionable
Beta
0.62
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NYSE:BLCO) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners